Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01977547Phase 3Completed
Phase 3, randomised, double-blind trial of red blood cells in anemia (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: New or Progressive Multiple Organ Dysfunction Syndrome at 28 days. Started Jan 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01977547.